Genetic Technologies
GENE
$2.18
Share price
-3.11%
Change (1 day)
105.66%
Change (1 year)
Categories
Genetic Technologies (GENE) - Total liabilities
Total liabilities on the balance sheet as of June 2023 : $2.44 M
According to Genetic Technologies's latest financial reports the company's total liabilities are $2.44 M. A company’s total liabilities is the sum of all current and non-current debts and obligations.
Genetic Technologies - Total liabilities on balance sheet (from 2004 to 2023)
Total liabilities by year
| Year | Total liabilities | Change |
|---|---|---|
| 2023-06-30 | $2.44 M | -18.69% |
| 2022-06-30 | $3 M | 178.2% |
| 2021-06-30 | $1.08 M | -4.11% |
| 2020-06-30 | $1.12 M | 7.44% |
| 2019-06-30 | $1.04 M | -2.48% |
| 2018-06-30 | $1.07 M | -8.46% |
| 2017-06-30 | $1.17 M | 11.86% |
| 2016-06-30 | $1.05 M | -22.22% |
| 2015-06-30 | $1.35 M | -70.74% |
| 2014-06-30 | $4.61 M | 97.42% |
| 2013-06-30 | $2.33 M | 11.99% |
| 2012-06-30 | $2.08 M | -7.39% |
| 2011-06-30 | $2.25 M | 4.59% |
| 2010-06-30 | $2.15 M | -30.84% |
| 2009-06-30 | $3.11 M | -1.71% |
| 2008-06-30 | $3.17 M | 10.27% |
| 2007-06-30 | $2.87 M | -7.3% |
| 2006-06-30 | $3.1 M | -26.5% |
| 2005-06-30 | $4.22 M | 22.35% |
| 2004-06-30 | $3.44 M | 97.11% |
| 2003-06-30 | $1.74 M | 29.8% |
| 2002-06-30 | $1.34 M | 38.04% |
| 2001-06-30 | $0.97 M |
Total liabilities for similar companies or competitors
| Company | Total liabilities | differencediff. | Country |
|---|---|---|---|
 Thermo Fisher Scientific TMO | $51.88 B | 2,121,858.20% | 🇺🇸 USA |
 Quest Diagnostics
DGX | $7.60 B | 310,889.33% | 🇺🇸 USA |
 Danaher DHR | $30.99 B | 1,267,660.01% | 🇺🇸 USA |
 LabCorp LH | $8.83 B | 361,218.56% | 🇺🇸 USA |
 Compugen CGEN | $55.77 M | 2,181.09% | 🇮🇱 Israel |
 Neogen NEOG | $1.45 B | 59,400.63% | 🇺🇸 USA |
 Myriad Genetics MYGN | $0.36 B | 14,758.29% | 🇺🇸 USA |
 Eterna Therapeutics ERNA | $46.89 M | 1,818.08% | 🇺🇸 USA |